PKR-dependent inflammatory signals

Science Signaling

Volumn 5, Issue 247, 2012, Pages

  Kang, Rui ^a   Tang, Daolin ^a  

^a UNIVERSITY OF PITTSBURGH CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE TRIPHOSPHATE; GAMMA INTERFERON; HIGH MOBILITY GROUP B1 PROTEIN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INFLAMMASOME; INTERFERON REGULATORY FACTOR 3; INTERLEUKIN 18; INTERLEUKIN 1BETA CONVERTING ENZYME; PROTEIN KINASE R; URATE;

AUTOPHAGY; BACTERIAL INFECTION; CELL STRESS; ENZYME ACTIVITY; ENZYME REGULATION; ESCHERICHIA COLI; EXOCYTOSIS; GENE DELETION; IMMUNE RESPONSE; MACROPHAGE; NONHUMAN; PRIORITY JOURNAL; PROTEIN SECRETION; REVIEW; SIGNAL TRANSDUCTION; VIRUS INFECTION;

ANIMALS; EIF-2 KINASE; EXTRACELLULAR SIGNAL-REGULATED MAP KINASES; HMGB1 PROTEIN; HUMANS; INFLAMMASOMES; INFLAMMATION; INTERFERON REGULATORY FACTOR-3; SIGNAL TRANSDUCTION;

EID: 84868148599     PISSN: 19450877     EISSN: 19379145     Source Type: Journal    
DOI: 10.1126/scisignal.2003511     Document Type: Review

References (35)

1. K. Schroder, J. Tschopp, The inflammasomes. Cell 140, 821-832 (2010).
2. V. A. Rathinam, S. K. Vanaja, K. A. Fitzgerald, Regulation of inflammasome signaling. Nat. Immunol. 13, 333-2 (2012).
3. B. Lu, T. Nakamura, K. Inouye, J. Li, Y. Tang, P. Lundbäck, S. I. Valdes-Ferrer, P. S. Olofsson, T. Kalb, J. Roth, Y. Zou, H. Erlandsson-Harris, H. Yang, J. P. Ting, H. Wang, U. Andersson, D. J. Antoine, S. S. Chavan, G. S. Hotamisligil, K. J. Tracey, Novel role of PKR in inflammasome activation and HMGB1 release. Nature 488, 670-674 (2012).
4. T. Strowig, J. Henao-Mejia, E. Elinav, R. Flavell, Inflammasomes in health and disease. Nature 481, 278-286 (2012).
5. E. Meurs, K. Chong, J. Galabru, N. S. Thomas, I. M. Kerr, B. R. Williams, A. G. Hovanessian, Molecular cloning and characterization of the human double-stranded RNA-activated protein kinase induced by interferon. Cell 62, 379-390 (1990).
6. A. E. Koromilas, S. Roy, G. N. Barber, M. G. Katze, N. Sonenberg, Malignant transformation by a mutant of the IFN-inducible dsRNA-dependent protein kinase. Science 257, 1685-1689 (1992).
7. S. Balachandran, G. N. Barber, PKR in innate immunity, cancer, and viral oncolysis. Methods Mol. Biol. 383, 277-301 (2007).
8. B. R. Williams, Signal integration via PKR. Sci. STKE 2001, re2 (2001).
9. M. A. García, J. Gil, I. Ventoso, S. Guerra, E. Domingo, C. Rivas, M. Esteban, Impact of protein kinase PKR in cell biology: From antiviral to antiproliferative action. Microbiol. Mol. Biol. Rev. 70, 1032-1060 (2006).
10. K. C. Goh, M. J. deVeer, B. R. Williams, The protein kinase PKR is required for p38 MAPK activation and the innate immune response to bacterial endotoxin. EMBO J. 19, 4292-4297 (2000).
11. T. Nakamura, M. Furuhashi, P. Li, H. Cao, G. Tuncman, N. Sonenberg, C. Z. Gorgun, G. S. Hotamisligil, Double-stranded RNA-dependent protein kinase links pathogen sensing with stress and metabolic homeostasis. Cell 140, 338-348 (2010).
12. M. Zamanian-Daryoush, T. H. Mogensen, J. A. DiDonato, B. R. Williams, NF-kappaB activation by double-stranded-RNA-activated protein kinase (PKR) is mediated through NF-kappaB-inducing kinase and IkappaB kinase. Mol. Cell. Biol. 20, 1278-1290 (2000).
13. M. C. Bonnet, R. Weil, E. Dam, A. G. Hovanessian, E. F. Meurs, PKR stimulates NF-kappaB irrespective of its kinase function by interacting with the IkappaB kinase complex. Mol. Cell. Biol. 20, 4532-4542 (2000).
14. P. Zhang, C. E. Samuel, Induction of protein kinase PKR-dependent activation of interferon regulatory factor 3 by vaccinia virus occurs through adapter IPS-1 signaling. J. Biol. Chem. 283, 34580-34587 (2008).
15. C. S. McAllister, A. M. Toth, P. Zhang, P. Devaux, R. Cattaneo, C. E. Samuel, Mechanisms of protein kinase PKR-mediated amplification of beta interferon induction by C protein-deficient measles virus. J. Virol. 84, 380-386 (2010).
16. S. P. Srivastava, K. U. Kumar, R. J. Kaufman, Phosphorylation of eukaryotic translation initiation factor 2 mediates apoptosis in response to activation of the double-stranded RNA- dependent protein kinase. J. Biol. Chem. 273, 2416-2423 (1998).
17. B. Levine, N. Mizushima, H. W. Virgin, Autophagy in immunity and inflammation. Nature 469, 323-335 (2011).
18. P. J. Vernon, D. Tang, Eat-Me: Autophagy, phagocytosis, and reactive oxygen species signaling. Antioxid. Redox Signal. 10.1089/ars.2012.4810 (2012).
19. J. Gil, M. Esteban, The interferon-induced protein kinase (PKR), triggers apoptosis through FADD-mediated activation of caspase 8 in a manner independent of Fas and TNF-alpha receptors. Oncogene 19, 3665-3674 (2000).
20. S. Balachandran, C. N. Kim, W. C. Yeh, T. W. Mak, K. Bhalla, G. N. Barber, Activation of the dsRNA-dependent protein kinase, PKR, induces apoptosis through FADD-mediated death signaling. EMBO J. 17, 6888-6902 (1998).
21. L. C. Hsu, J. M. Park, K. Zhang, J. L. Luo, S. Maeda, R. J. Kaufman, L. Eckmann, D. G. Guiney, M. Karin, The protein kinase PKR is required for macrophage apoptosis after activation of Toll-like receptor 4. Nature 428, 341-345 (2004).
22. Z. Tallóczy, W. Jiang, H. W. Virgin 4th, D. A. Leib, D. Scheuner, R. J. Kaufman, E. L. Eskelinen, B. Levine, Regulation of starvation- and virus-induced autophagy by the eIF2alpha kinase signaling pathway. Proc. Natl. Acad. Sci. U.S.A. 99, 190-195 (2002).
23. U. Andersson, K. J. Tracey, HMGB1 is a therapeutic target for sterile inflammation and infection. Annu. Rev. Immunol. 29, 139-162 (2011).
24. D. Tang, R. Kang, H. J. Zeh 3rd, M. T. Lotze, High-mobility group box 1, oxidative stress, and disease. Antioxid. Redox Signal. 14, 1315-1335 (2011).
25. D. Tang, R. Kang, C. B. Coyne, H. J. Zeh, M. T. Lotze, PAMPs and DAMPs: Signal 0s that spur autophagy and immunity. Immunol. Rev. 249, 158-175 (2012).
26. D. Tang, M. T. Lotze, Tumor immunity times out: TIM-3 and HMGB1. Nat. Immunol. 13, 808-810 (2012).
27. T. Bonaldi, F. Talamo, P. Scaffidi, D. Ferrera, A. Porto, A. Bachi, A. Rubartelli, A. Agresti, M. E. Bianchi, Monocytic cells hyperacetylate chromatin protein HMGB1 to redirect it towards secretion. EMBO J. 22, 5551-5560 (2003).
28. M. Lamkanfi, A. Sarkar, L. Vande Walle, A. C. Vitari, A. O. Amer, M. D. Wewers, K. J. Tracey, T. D. Kanneganti, V. M. Dixit, Inflammasome-dependent release of the alarmin HMGB1 in endotoxemia. J. Immunol. 185, 4385-4392 (2010).
29. S. B. Willingham, I. C. Allen, D. T. Bergstralh, W. J. Brickey, M. T. Huang, D. J. Taxman, J. A. Duncan, J. P. Ting, NLRP3 (NALP3, Cryopyrin) facilitates in vivo caspase-1 activation, necrosis, and HMGB1 release via inflammasome-dependent and -independent pathways. J. Immunol. 183, 2008-2015 (2009).
30. M. Sahoo, I. Ceballos-Olvera, L. del Barrio, F. Re, Role of the inflammasome, IL-1β, and IL-18 in bacterial infections. ScientificWorldJournal 11, 2037-2050 (2011).
31. M. Gale Jr., C. M. Blakely, D. A. Hopkins, M. W. Melville, M. Wambach, P. R. Romano, M. G. Katze, Regulation of interferon-induced protein kinase PKR: Modulation of P58IPK inhibitory function by a novel protein, P52rIPK. Mol. Cell. Biol. 18, 859-871 (1998).
32. N. Dupont, S. Jiang, M. Pilli, W. Ornatowski, D. Bhattacharya, V. Deretic, Autophagy-based unconventional secretory pathway for extracellular delivery of IL-1β. EMBO J. 30, 4701-4711 (2011).
33. D. Tang, R. Kang, K. M. Livesey, C. W. Cheh, A. Farkas, P. Loughran, G. Hoppe, M. E. Bianchi, K. J. Tracey, H. J. Zeh 3rd, M. T. Lotze, Endogenous HMGB1 regulates autophagy. J. Cell Biol. 190, 881-892 (2010).
34. E. Venereau, M. Casalgrandi, M. Schiraldi, D. J. Antoine, A. Cattaneo, F. De Marchis, J. Liu, A. Antonelli, A. Preti, L. Raeli, S. S. Shams, H. Yang, L. Varani, U. Andersson, K. J. Tracey, A. Bachi, M. Uguccioni, M. E. Bianchi, Mutually exclusive redox forms of HMGB1 promote cell recruitment or proinflammatory cytokine release. J. Exp. Med. 209, 1519-1528 (2012).
35. D. Tang, R. Kang, C. W. Cheh, K. M. Livesey, X. Liang, N. E. Schapiro, R. Benschop, L. J. Sparvero, A. A. Amoscato, K. J. Tracey, H. J. Zeh, M. T. Lotze, HMGB1 release and redox regulates autophagy and apoptosis in cancer cells. Oncogene 29, 5299-5310 (2010).